Cite
HARVARD Citation
Wallace, J. et al. (n.d.). A3 A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346). Journal of the Canadian Association of Gastroenterology. pp. 7-8. [Online].